Why Aurora Cannabis (TSX:ACB) Stock Is Headed for All-Time Highs Over the Next Year

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is headed towards profitability and is pursuing big partnerships after a new hire. The stock should benefit from these developments even at a high valuation.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is the second-largest cannabis company listed on the TSX going by market cap. Shares of Aurora were up 0.43% in late-morning trading on May 22. The stock has jumped 71% in 2019 so far.

Aurora reached an all-time high immediately before recreational cannabis legalization in mid-October 2018. The stock suffered a sharp retreat afterwards and bottomed out in the final weeks of 2018. Cannabis stocks have broadly performed well in 2019, even as slumping sales have weighed on the earnings of some of the largest producers. This environment has attracted the interest of short-sellers.

Investors should be excited about Aurora’s prospects going forward. It is well positioned to secure large verticals with companies after its big March hire. A production ramp-up and a maturation of its business means that Aurora is on track to achieve profitability in the near future.

Aurora released its third-quarter 2019 results on May 14. Production volume at Aurora increased 99% from the prior quarter and 1,200% year over year to 15,590 kilograms. As expected, Aurora’s production is ramping up and the majority was harvested in the latter half of Q3 2019. Average selling price per gram decreased marginally due to product mix and extraction capacity constraints. Cash cost per gram dropped 26% to $1.42.

Adjusted EBITDA loss improved by 20% to $36.6 million with Aurora intensely focused on profitability. It grew its medical patient base by 5% to 77,316. Investors will be hoping it can increase its proportion of recreational sales going forward. Right now, the company is churning ahead at a 50/50 split, while companies like Canopy Growth now derive a comfortable majority of sales revenue from recreational consumers.

Some analysts are confident that Aurora will post its first positive EBITDA in Q4 2019. Production is expected to aggressively ramp up in the final months of the year. Does that mean Aurora stock will rise to new heights?

Aurora’s recent run-up was largely due to the addition of Nelson Peltz as a strategic advisor. There is hope that Peltz will be able to facilitate lucrative partnerships for Aurora, as it has yet to make the kind of splash other producers have made. Canopy Growth secured a multi-billion partnership with alcohol giant Constellation Brands last year, which sparked a huge run-up for the stock.

Aurora CCO Cam Battley recently revealed that Aurora planned to follow its peers Tilray and Canopy Growth with a push into the U.S. market. U.S. federal law still bans recreational cannabis, but producers are betting on movement in this area in the coming years. The U.S. cannabis market would be one of the most valuable in the world if it moves forward with broader legalization.

Battley has said that Aurora would look to structure deals like Canopy’s tentative agreement to acquire Acreage Holdings. This way Aurora can avoid violating exchange rules while setting the table in preparation for U.S. legalization. The company hopes to fund future deals on the back of improved cash flow instead of relying on large share issuances.

Aurora stock is currently trading around the middle of its 52-week range. Like most in this sector, Aurora is a speculative buy, but there is reason for optimism as Q4 2019 is shaping up to be a big one for the company.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan owns shares of Aurora Cannabis.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »